Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.2.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 7,833 $ 16,522
Note receivable - LINICO 400 600
Accounts receivable 0 67
Inventory 908 929
Prepaid expenses and other current assets 174 181
Total current assets 9,315 18,299
Non-current assets    
Property, plant and equipment, net 17,009 10,347
Intellectual property, net 191 281
Other assets 7,143 4,673
Total non-current assets 24,343 15,301
Total assets 33,658 33,600
Current liabilities    
Accounts payable 1,679 1,836
Accrued Expenses 2,908 2,467
Lease liability, current portion 288 275
Note payable, current portion 2,979 35
Total current liabilities 7,854 4,613
Lease liability, non-current portion 593 0
Note payable, non-current portion 0 2,923
Total liabilities 8,447 7,536
Commitments and contingencies (see Note 12)
Stockholders’ equity    
Common stock; $0.001 par value; 300,000,000 shares authorized; 134,257,193 and 133,800,547, shares issued and outstanding as of June 30, 2024, respectively and 108,308,661 and 107,880,095, shares issued and outstanding as of December 31, 2023, respectively 134 108
Additional paid-in capital 260,554 249,687
Accumulated deficit (235,117) (223,215)
Treasury stock, at cost; common shares: 456,646 and 428,566 as of June 30, 2024 and December 31, 2023, respectively (360) (516)
Total stockholders’ equity 25,211 26,064
Total liabilities and stockholders’ equity $ 33,658 $ 33,600